Reduction processing of an adverse consequence of Myocardial Infarction in a patient using antagonist of TGF beta.

• 收藏
• 分享

专利权人:

GENZYME CORPORATION.

发明人:

AKITA, GEOFFREY Y.,LONNING, SCOTT,GREGORY, RICHARD C., JR,KUDEJ, AMELIA B.

申请号：

CL2013000586

公开号：

CL2013000586A1

申请日:

2013.02.28

申请国别(地区):

CL

年份:

2013

代理人:

摘要：

Disclosed herein is a method of treating a patient suffering a myocardial infarction, particularly an acute myocardial infarction, or of reducing an adverse consequence of a myocardial infarction in a patient comprising administering an antagonist of TGF-beta to the patient during the acute stage of the myocardial infarction.PROCEDIMIENO DE REDUCCION DE UNA CONSECUENCIA ADVERSA DE UN INFARTO DE MIOCARDIO EN UN PACIENTE UTILIZANDO ANTAGONISTA DE TGF-BETA.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/